Quantcast

Latest Bioavailability Stories

2014-08-05 23:03:14

OMICS Group International schedules its 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during September 29 to October 01, 2014 at Baltimore, USA with an aim to Revolutionize the Next Generation Medicines using innovative Bioavailability and Bioequivalence (BA/BE) approaches and Studies. Los Angeles, CA (PRWEB) August 05, 2014 Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile...

2014-08-05 12:31:21

Innovative Technology and Pharmacokinetic (PK) Studies Lead Path to CBD efficacy. NEWARK, N.J., Aug. 5, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced the beginning of the second phase of development towards the launch of its proprietary line of natural cannabidiol (CBD)-based nutritional supplements it is developing in partnership with Terra Tech Corp (OCTBB: TRTC). Bioavailability is an important...

2014-07-30 23:16:49

Dignity Sciences Limited finds that orally administered DGLA distributes well to the skin resulting in high dermal bioavailability Dublin, Ireland (PRWEB) July 30, 2014 Dignity Sciences Limited, a privately held biopharmaceutical company, today announced the successful completion of a Phase I trial with DS107G, an oral formulation of Dihomo Gamma Linolenic Acid (DGLA). This study was a randomized, placebo-controlled, double-blind, single-ascending and multiple dose Phase I clinical trial...

2014-07-11 16:23:25

FALLS CHURCH, Va., July 11, 2014 /PRNewswire/ -- Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds. Due to the complex nature of a multitude of existing as well as newly-discovered active ingredients,...

2014-06-12 23:09:56

MarketReportsOnline.com adds "Global IV Iron Drugs Market Report: 2014 Edition" report to its research store. Dallas, Texas (PRWEB) June 12, 2014 Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Also, this method ensures...

2014-05-20 12:33:26

SALT LAKE CITY and TORONTO, May 20, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company aiming to make use of innovations in drug delivery for the development of improved novel formulations and alternative dosage forms for existing biologically active molecules. An introduction and a description of the company's platform delivery and formulation technology is summarized below: An analysis of currently marketed drugs identified a...

2014-04-28 12:29:06

Complex combination of factors are driving the market of specialty excipients for OSDF globally PARSIPPANY, N.J., April 28, 2014 /PRNewswire/ -- On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at nearly $2.3 billion in the United States, Europe, India, and China, according to recently published Specialty Excipients for Oral Solid Dosage Form Pharmaceuticals Global Series:...

2014-04-18 23:08:24

OMICS Group announces the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA with the theme “Innovative Approaches of BABE to Revolutionize the Next Generation Medicine” Los Angeles, CA (PRWEB) April 18, 2014 BABE-2014 is all set to explore the innovations, advancements in the field of pharmaceutical industry, which shows significant impact on the development of new and improved generic drugs. These...

2014-02-28 23:28:12

Updated patent expands protection of technology to enhance lunasin bioactivity and promote bioavailability. Chesterfield, MO (PRWEB) February 28, 2014 Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the US Patent and Trademark Office has issued an expanded composition of matter patent for LunaRich® technology. LunaRich is a Reliv-exclusive nutritional ingredient. The updated patent further protects...

2014-02-19 16:24:33

February 2014 - Phase4 Pharmaceutical - AgeForce® Division introduces the first 100% bioavailable resveratrol supplement in a transdermal time-release patch. HALLANDALE BEACH, Fla., Feb. 19, 2014 /PRNewswire-iReach/ -- The Problem: Less than 1% of any orally ingested resveratrol supplement survives digestive stomach acid, intestinal bacteria, and first-pass liver functions, before entering the bloodstream. The Solution: According to the company's CEO Steve Lapidus: "We needed to bypass the...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.